Table 2.
Within 4 weeks before surgery* | D0 = day of first desmopressin infusion |
D1 | D2 | D3 | 4–8 weeks after FVIII treatment | ||||||||
Time–bolus infusions† | Baseline | Pre | Post | Peak | Post-treat | Pre | Post | Peak | Pre | Post | Peak | Trough | |
Time–continuous infusion‡ | Baseline | Pre | Post | Peak | Post-treat | Pre | Post | Preadjust | Pre | Post | Preadjust | Steady state | |
Primary endpoint | X | X | X | ||||||||||
Sodium | X | X | X | X | X | ||||||||
Neutralising antibodies | X | X |
Grey indicates obligatory measurements.
FVIII measurements are shown here until day 3 after start of combination treatment. Monitoring will continue if treatment is still necessary.
*Only in case of elective surgery, otherwise before first desmopressin administration.
†Pre, before desmopressin; post, after desmopressin; peak, after FVIII concentrate; post-treat=after surgery; in case of bleeding: 2–6 hours after desmopressin, trough, before next dose of FVIII concentrate.
‡Pre, before desmopressin; post, after desmopressin; peak, after loading dose FVIII concentrate; post-treat, after surgery; in case of bleeding: 2–6 hours after desmopressin; preadjust, before dosage; steady state, FVIII measurement at random time point.